RACE IT: A prospective, single arm, multicenter, phase II-trial to assess safety and efficacy of preoperative radiation therapy before radical cystectomy combined with immunotherapy in locally advanced urothelial carcinoma of the bladder (AB 65/18)

被引：1
|
作者：
Schmid, S. C. [1 ]
Beckert, F. [1 ]
Koll, F. [1 ]
Roedel, C. [2 ]
Seitz, A. K. [3 ]
Maisch, P. [1 ]
Sauter, A. [4 ]
Kuebler, H. [3 ]
Flentje, M. [5 ]
Combs, S. E. [6 ]
Schiller, K. [6 ]
Gschwend, J. [1 ]
Retz, M. [1 ]
机构：
[1] TUM Tech Univ Munich, Dept Urol, Rechts Isar Med Ctr, Munich, Germany
[2] Univ Klinikum Frankfurt Johannes Wolfgang Goethe, Radiotherapy, Frankfurt, Germany
[3] Univ Clin Wurzburg, Dept Urol, Wurzburg, Germany
[4] TUM Tech Univ Munich, Dept Radiol, Rechts Isar Med Ctr, Munich, Germany
[5] Univ Clin Wurzburg, Dept Radiat Oncol, Wurzburg, Germany
[6] Tech Univ Muenchen, Dept Radiat Oncol, Klinikum Rechts Isar, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.2068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
797TiP
引用
收藏
页码：S605 / S605
页数：1
相关论文
共 28 条
  • [21] Safety and efficacy of pembrolizumab combined with paclitaxel and cisplatin as a neoadjuvant treatment for locally advanced resectable (stage III) esophageal squamous cell carcinoma (Keystone-001): Interim analysis of a prospective, single-arm, single-center, phase II trial
    Shang, X.
    Zhang, C.
    Zhao, G.
    Zhang, W.
    Liu, L.
    Duan, X.
    Yue, J.
    Ma, Z.
    Chen, C.
    Meng, B.
    Ren, X.
    Jiang, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S1428 - S1429
  • [22] Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial
    Chang, Chen
    Cai, Zhaolun
    Cheng, Ke
    Shen, Chaoyong
    Zhang, Bo
    Chen, Zhixin
    Yin, Yuan
    Cao, Dan
    UPDATES IN SURGERY, 2025, 77 (01) : 165 - 174
  • [23] Efficacy and safety of sequential neoadjuvant chemotherapy and short-course radiation therapy followed by delayed surgery in locally advanced rectal cancer: a single-arm phase II clinical trial with subgroup analysis between the older and young patients
    Bananzadeh, Alimohammad
    Hafezi, Ali Akbar
    Nguyen, NamPhong
    Omidvari, Shapour
    Mosalaei, Ahmad
    Ahmadloo, Niloofar
    Ansari, Mansour
    Mohammadianpanah, Mohammad
    RADIATION ONCOLOGY JOURNAL, 2021, 39 (04): : 270 - 278
  • [24] Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S-1 for neoadjuvant therapy of locally advanced gastric cancer with HER2 overexpression: Preliminary results of a prospective, single-arm, phase II study
    Chai, Jie
    Wang, Longgang
    Liu, Luguang
    Liu, Bing
    Sun, Dong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S-1 for neoadjuvant therapy of locally advanced gastric cancer with HER2 overexpression: Preliminary results of a prospective, single-arm, phase II study
    Chai, J.
    Wang, L.
    Liu, L.
    Liu, B.
    Sun, D.
    ANNALS OF ONCOLOGY, 2024, 35 : S908 - S908
  • [26] Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)
    Shang, Xiaobin
    Zhao, Gang
    Liang, Fei
    Zhang, Chen
    Zhang, Weihong
    Liu, Liang
    Li, Runmei
    Duan, Xiaofeng
    Ma, Zhao
    Yue, Jie
    Chen, Chuangui
    Meng, Bin
    Ren, Xiubao
    Jiang, Hongjing
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (04)
  • [27] Neoadjuvant Therapy Schemes combined with adjuvant Therapy for Patients with muscle invasive Bladder Cancer before or after radical Cystectomy A randomized, open, multicenter, global Phase-III Study to Determine the Efficacy and Safety of Durvalumab in combination with Gemcitabine plus Cisplatin (G plus C) for neoadjuvant Treatment, followed by Durvalumab alone for adjuvant Treatment in Patients with muscle invasive Bladder Cancer ( NIAGARA) - AUO AB 74/20
    Rexer, Heidrun
    Kuebler, Hubert
    Retz, Margitta
    AKTUELLE UROLOGIE, 2021, 52 (03) : 220 - 221
  • [28] Phase II, multicenter, randomized, open-label, parallel-arm, umbrella study JAVELIN Bladder Medley of avelumab (MSB0010718C) in combination with sacituzumab govitecan, M6223 and NKTR-255 as maintenance therapy in participants with locally advanced or metastatic urothelial carcinoma treated with first-line platinum-containing therapy (1L) chemotherapy has not progressed. - JAVELIN Bladder Medley - AB 88/23 from AUO
    Rexer, Heidrun
    Banek, Severine
    Merseburger, Axel S.
    AKTUELLE UROLOGIE, 2023, 54 (06) : 438 - 440
123